NCT03577262View on ClinicalTrials.gov

A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 23, 2018

Primary Completion Date

August 2, 2019

Study Completion Date

August 2, 2019

Conditions
HealthyAlzheimer Disease
Interventions
OTHER

[11C]-UCB-J

IV radioligand given prior to and during positron emission tomography (PET) scan

Trial Locations (3)

Unknown

VU Medical Center, Dept. Radiology and Nuclear Medicine, Amsterdam

QPS Netherlands B.V., Groningen

University Medical Center Groningen, Nuclear Medicine and Molecular Imaging, Groningen

Sponsors

Lead Sponsor

Alkermes, Inc.
All Listed Sponsors
collaborator

QPS Netherlands B.V.

INDUSTRY

collaborator

University Medical Center Groningen

OTHER

collaborator

Amsterdam UMC, location VUmc

OTHER

lead

Alkermes, Inc.

INDUSTRY